Forty-eight states and the District of Columbia—excluding Wyoming and West Virginia—on Thursday announced a $60 million settlement with medical technology company C.R. Bard Inc., over the corporation’s marketing of surgical mesh products.
The 27-page settlement agreement between the states and Bard—a subsidiary of New Jersey-based Becton, Dickinson and Co.—says the company signed off on the settlement without admitting any liability.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Not a Bloomberg Law Subscriber?
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]